FDA Details Ethics Panel Duties In Clinical Trials

Law360, New York (August 27, 2013, 2:48 PM EDT) -- The U.S. Food and Drug Administration on Tuesday described how it expects ethics panels to oversee the integrity of clinical trials, issuing guidance on the vetting of both researchers and the venues used for studies.

The document appeared to contain little in the way of new directives, instead functioning as a centralized collection of statements that the FDA has issued in previous guidances and direct communications with so-called institutional review boards.

IRBs tend to be internal bodies that monitor research at institutions, but they also can...
To view the full article, register now.